Skip to main content
. 2022 Dec 26;15(1):143. doi: 10.3390/cancers15010143

Table 3.

Enzymatic inhibitory activities of thiazolo[5,4-b]pyridine derivatives 6r, 6s, and 7c against c-KIT V560G/D816V.

Entry IC50 (μM) a
c-KIT V560G/D816V
imatinib 37.93 ± 8.68
sunitinib 3.98 ± 1.18
6r 4.77 ± 0.38
6s 7.67 ± 2.64
7c 5.07 ± 0.71

a ADP-Glo kinase assay.